Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity




Rainio EM, Ahlfors H, Carter KL, Ruuska M, Matikainen S, Kieff E, Koskinen PJ

PublisherACADEMIC PRESS INC ELSEVIER SCIENCE

2005

Virology

VIROLOGY

VIROLOGY

333

2

201

206

6

0042-6822

DOIhttps://doi.org/10.1016/j.virol.2005.01.001



Latent Epstein-Barr virus (EBV) infection is strongly associated with B-cell proliferative diseases such as Burkitt's lymphoma. Here we show that the oncogenic serine/threonine kinases Pim-1 and Pim-2 enhance the activity of the viral transcriptional activator EBNA2. During EBV infection of primary B-lymphocytes, the mRNA expression levels of pint genes, especially of pim-2, are upregulated and remain elevated in latently infected B-cell lines. Thus, EBV-induced upregulation of Pim kinases and Pim-stimulated EBNA2 transcriptional activity may contribute to the ability of EBV to immortalize B-cells and predispose them to malignant growth. (C) 2005 Elsevier Inc. All rights reserved.

Last updated on 2024-26-11 at 13:59